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Conventional Papanicolaou smear method is still commonly used for cervical cancer screening in Japan, despite the liquid-based
cytology (LBC) that has become a global tendency in the world recently. One of the obstacles in the way of popularization of
this method seems to be the confusion as to diagnosis upon cervical glandular lesions. We performed comparison study between
LBC and conventional Papanicolaou smear about cytological diagnosis using split-sample method in 4522 patients. In 13 cases
analyses, which were reported with either AGC or adenocarcinoma by either method, LBC tends to be milder than that by
conventional smear, however, the credibility of LBC is considered to be near to that of conventional smear with regard to screening
for glandular abnormalities. These results indicate that cervical cancer screening should shift to LBC under the enough experience
and appropriate dealing with the cytological diagnosis.
1.Introduction
Uterine cervical cancer is still the most commonly diagnosed
cancer among women worldwide, taking second place only
after breast cancer [1–4]. The incidence and mortality from
cervical cancer decreased considerably in most industrial
countries due to lower incidence and the introduction
of screening [5, 6]. On the other hand, malignant or
precancerous lesions of glandular cells in uterine cervix
are increasing recently, as reported that the incidence of
adenocarcinomaofJapanis16.8%in2009,andmanystudies
reported higher mortality rate of cervical adenocarcinoma
[7–12]. The screenings of the glandular lesions are thought
to be diﬃcult in comparison with those of the squamous
epithelium type, although those early diagnoses become
more important for prognosis improvement.
In late years, Japan Association of Obstetricians and
Gynecologistsannouncedastandardizedsystemofterminol-
ogyreﬂectedbytheBethesdasystem(TBS)andthescreening
of cervical lesions are being performed based on this system
[13]. In this new Japanese system, increasing numbers of
facilitiescometouseLBC,whichisaglobaltendency,despite
the premise to use conventional smears for sampling. In
many reports of the comparison studies between LBC and
conventional smear with clinical and histological followups,
LBC is better than conventional smear in detecting biopsy-
proven disease and in screening out benign abnormalities in
t e r m so fs q u a m o u sl e s i o n s[ 14–22]. However, it still remains
unclear how to evaluate the cytological diagnosis of the
glandular lesion in the new system using LBC.
We recently started TBS application using both of conve-
ntionalsmearsandtheliquid-basedcytologyasamulticenter
study which simultaneously investigates HPV infection. In
this study, we examined the correlation between conven-
tional smears and LBC in the cytological diagnosis of the
glandular lesion in order to make it clear whether LBC has2 Pathology Research International
Table 1: Relationship between conventional smear and ThinPrep method.
ThinPrep (TP)
NILM ASC-US ASC-H AGC LSIL HSIL HSILw/FSFI AIS SCC ADC ADSQ Total
Conventional Smear
(CS)
NILM 3985 35 1 1 33 7 0 0 0 0 0 4062
ASC-US 47 12 0 0 10 2 0 0 0 0 0 71
ASC-H 2 2 1 021 1 0 00 0 9
AGC 5 1 0 2 00 0 0 00 0 8
LSIL 73 17 0 0 104 27 0 0 0 0 0 221
HSIL 5 4 0 0 19 77 2 0 5 0 0 112
HSILw/FSFI 0 0 1 0 0 0 0 00 0 0 3
AIS 0 0 0 0 0 0 0 0 00 0 0
SCC 1 0 0 0 0 4 2 0 15 00 2 5
ADC 1 1 0 3 0 0 0 0 1 2 01 0
ADSQ 0 0 0 0 0 0 0 0 0 1 0 1
Total 4119 72 3 6 168 120 5 0 25 4 0 4522
NILM: negative for intraepithelial lesion or malignancy; ASC-US: atypical squamous cells of undetermined signiﬁcance; ASC-H: atypical squamous
cells, cannot exclude high-grade squamous intraepithelial lesion; AGC: atypical glandular cells; LSIL: low-grade intraepithelial cells; HSIL: high-grade
intraepithelial lesion; FSFI: HSIL features suspicious for invasion; AIS: adenocarcinoma in-situ; SCC: squamous cell carcinoma; ADC: adenocarcinoma;
ADSQ: adenosquamous cell carcinoma.
the diagnosis precision that is equivalent to conventional
smear.
2.MaterialsandMethods
At eight institutions in Hiroshima prefecture, including the
key institution, National Hospital Organization, Japan, and
Kure Medical Center/Chugoku Cancer Center (NHOKM-
CCCC), from November 2007 to July 2009, 4522 cases
were retrieved and analyzed as split-sample studies. Initially,
smears were taken in the routine fashion using EndoCervex-
Brush (Rovers Medical Devices B. V., Oss, The Netherlands)
in each institution, ﬁxed either by immersion in 95% ethanol
or by spray ﬁxation with a pump-action spray, and preserved
before staining (conventional smear, CS). The residual cells
remaining on the sampler were rinsed into vials containing
20mL of preservative, then, sent to the key institution, fol-
lowed by the treatment according to the ThinPrep (Hologic,
Marlboruogh, Mass, USA) protocol (ThinPrep, TP). An
additional sample was obtained with a dacron swab and
placed in specimen transport medium (STM) for future
human papillomavirus (HPV) DNA testing. Specimens
prepared by each method underwent Papanicolaou staining
and was enclosed.
The specimens are initially screened by cytotechnologists
in the manner of TBS. The screening was performed as
blinded experiment, namely, each specimen by the CS or
TP method was diagnosed by the other screener, which
did not know the information by the other methods nor
HPV data. Possibly abnormal specimens are referred to
senior cytotechnologists and cytopathologists for review.
The specimens diagnosed as abnormal in each institution
were shipped to the key institution to be reviewed by the
central committee, which consists of the senior pathologists,
for determining the ﬁnal cytological diagnosis. Prior to the
study, all the cytotechnologists and the cytopathologists were
engaged in this study who trained in the use of TBS and
acquired the certiﬁcation of ThinPrep test presided over in
Cytyc Co. (Marlborough, Mass).
Histological examination was also performed in some
cases following the cytology or after few periods, if required
for clinical reason. The histological diagnosis was made by
pathologist independently from cytology. In all the cases
other than NILM, which were diagnosed by either CS and/or
TP method, cancer-associated 16 HPV genotyping (types 16,
58, 52, 51, 56, 31, 18, 39, 66, 59, 6, 33, 30, 35, 45, and 11)
was performed by multiplex PCR as described previously
using the remaining samples in the TP preservative ﬂuid
[23].Alltheinstitutionshavefullreviewsandapprovalsfrom
respective Institutional Review Boards. Statistical analyses
were performed in the key institution. Photographs of
cytology by CS and TP as well as histological ones were
displayed in representative cases.
3. Results
We initially performed analysis in all the lesions of the
samples, including squamous ones, prior to the analysis
speciﬁc for glandular lesions. The cytological diagnosis in
TBS by CS or TP method in all the 4522 cases is shown in
Table 1. The average age of the patients was 46.1. Patients
whoconsultedduetomedicalcheckupwere13.8%andthose
who had any complaints were 89.3%. The number of cases
which diagnosed positive was 460 (10.2%) by CS and 403
(8.9%) by TP. Cytologically positive cases by each method
were categorized as follows: 49 cases of ASC (1.1%), 5 casesPathology Research International 3
Table 2: Up-graded case by ThinPrep method.
Conventional smear ThinPrep
Number ASC-US ASC-H AGC LSIL HSIL FSFI SCC/ADC Up-grading by TP
NILM 4062 35 1 1 33 7 0 0 77 1.90%
ASC-US 71 — — — 10 2 0 0 12 16.90%
ASC-H 9 — — — 2 1 1 0 4 44.40%
AGC 8 — — — 0 0 0 0 0 —
LSIL 221 — — — — 27 0 0 27 12.20%
HSIL 112 — — — — — 2 5 7 6.30%
Total 4483 35 1 1 45 37 3 5 127 2.80%
Table 3: Up-graded case by conventional smear method.
ThinPrep Conventional smear
Number ASC-US ASC-H AGC LSIL HSIL FSFI SCC/ADC Up-grading by TP
NILM 4119 47 2 5 73 5 0 2 134 3.30%
ASC-US 72 — — — 17 4 0 1 22 30.60%
ASC-H 3 — — — 0 0 1 0 1 33.30%
AGC 6 — — — 0 0 0 3 3 50.00%
LSIL 168 — — — — 19 0 0 19 11.30%
HSIL 120 — — — — — 2 4 6 5.00%
Total 4488 47 2 5 90 28 3 10 185 4.10%
Table 4: Glandular abnormalities in TBS.
Case Age CS TP HPV Histology in cervical biopsy
12 7 N I L M A G C( −)E n d o m e t r i a l p o l l y p
2 38 AGC NILM 56+ ND
3 54 AGC NILM 16+ Atypical endometrial hyperplasiaa
4 25 AGC NILM (−)N D
5 61 AGC NILM (−)N D
6 50 AGC AGC 52+ Endometrioid adenoca, G2a
7 36 AGC AGC 16+ ND
8 42 AGC NILM (−) Mild glandular dysplasia
97 4A G CA S C - U S ( −) clear cell carcinoma
10 58 AdenoCa AGC (−)N D
11 40 AdenoCa AdenoCa (−) Endometrioid adenoca, G1a
12 65 AdenoCa AGC (−) Endometrioid adenoca, G1>G2a
13 74 AdenoCa AGC (−)O v a r i a n c a n c e r b
aDisease existed in uterine corpus diagnosed in surgical samples.
bDiagnosed in surgical samples.
of AGC (0.11%), 73 cases of LSIL (1.7%), 5 cases of HSIL
(0.11%), 1 case of SCC (0.02%), 1 case of ADC (0.02%) in
CS, 36 cases of ASC (0.8%), 1 cases of AGC (0.02%), 33 cases
of LSIL (0.7%), and 7 cases of HSIL (0.15%), neither cases
of SCC nor ADC in TP were reparted. There was no large
variation of distribution of each category in each method.
The diagnoses by TP and CS corresponded with each other
in 4198 cases (92.8%).
Discrepancies in the diagnosis between CS and TP were
shown in Tables 2 and 3. There were 7 cases in which TP
method revealed HSIL and more, and CS was negative, as
well as 7 cases in whom HSIL and more were detected with
CS alone. All the other cases diagnosed as positive, either TP
orCSalone,were77and134,respectively.Inthecomparison
betweenCSandTPmethodsofallthecases,127(2.8%)were
up-graded by TP and 185 (4.1%) were up-graded by CS.
Within the limits of HSIL, FSFI, and SCC/SDC up-grading
was observed in 45 (1.0%) cases by TP and in 41 (0.9%)
cases in CS.
Table 4 presents the glandular abnormalities detected by
either TP or CS. Thirteen cases were reported with either
AGC or adenocarcinoma, including 12 cases diagnosed by4 Pathology Research International
(a) (b)
Figure 1: Case 9. (a) CS method. A small-crowded cluster is comprised of atypical cells, which have relatively distinct nuclei with indented
outlines, suggesting AGC. (b) TP method. Marginal number of atypical cells with dense cytosol in small monolayer cluster were diagnosed
as ASC-US (Papanicolaou; original magniﬁcation, x600, resp.).
CS and eight cases by TP. Seven cases were diagnosed as
either AGC or adenocarcinoma by both CS and TP methods.
Among eight cases which were diagnosed as AGC by CS,
four were NILM, one was ASC-US, and two were AGC by
TP. Similarly, three cases were diagnosed AGC and one case
was adenocarcinoma by TP out of four cases which were
adenocarcinoma by TP. Thus, this shows that the diagnosis
by TP tends to be milder than that by CS in terms of
glandular abnormalities. Histological ﬁnal diagnoses were
obtained from either surgical or biopsy samples in eight
cases; one benign, two hyperplasic, and ﬁve malignant
glandular lesions in the 12 cases. There is also one additional
case in which glandular abnormality was suspected due to
the presence of HPV infection. TP identiﬁed six (66.7%)
cases as either AGC or adenocarcinoma in these nine cases
presenting glandular abnormality, as CS did all nine cases.
With regard to screening for glandular abnormalities, the
credibility of TP method is considered to be near to that of
CS. Representative microscopic ﬁeld of cytological samples
from CS or TP method are exhibited in Figures 1 and 2.
4. Discussion
LBC preparation was approved for use originally in the
UnitedStatesin1996,reportedtoreducethenumberoffalse-
positive and false-negative smear results by the reason of
overcoming several drawbacks in conventional Papanicolaou
smear samples [22]. Also, it is one of the large advantages of
LBC that remaining specimen can be used for the additional
examination like HPV genotyping. In Japan, conventional
smear had been used for the screening until recently, but
many institutions have begun LBC in combination to TBS
and HPV DNA testing for past a few years. LBC seems to
become more and more general method for cervical cancer
screening in the future. On the other hand, it is a weak
point of LBC that evaluation of glandular abnormalities is
not carried out enough. It is reasonable to investigate the
capability for diagnosis of glandular abnormalities in cervix,
whichmaybecomemoreimportantdiseaseduetoincreasing
number of the patients.
In this study, there were not so much diﬀerences between
CS and TP in the detection rate of each category of positive
cases.Also,thedetectionrateofallthepositivecasesbyeither
CS or TP was similar to that reported previously [20, 21, 24].
In nine cases analyses, in which AGC or adenocarcinoma
were considered by histological examination or HPV infec-
tion status, screening as the abnormality to be AGC or more
was possible in nine cases by CS and in six cases by TP; thus,
CS method seems to be better in the point of accuracy for
screening. However, no typical cytological features, which
were considered to be cause of oversight, were observed in
TP samples. It is conﬁrmed that CS would be equivalent to
TP, if only good enough quality of specimen is provided.
On the other hand, the actual numbers of glandular
abnormalities are extremely low—only 13 cases in total, with
only eight cases with histological followup in this study,
including even more than 4000 total cases. These numbers
may be low and diﬃcult to perform statistical analysis on,
or draw deﬁnite conclusions from. The incidence of cervical
adenocarcinoma in Japan accounts for 16.8% of whole
cervical cancer as described, and this may not correspond
to the number of cases of the glandular abnormalityPathology Research International 5
(a) (b)
Figure 2: Case 12. (a) CS method. A loosely cohesive and crowded tissue fragment displays malignant cells, which have sharp-ended nuclei
with enlarged nucleoli, in the myxoid and collagenized matrix, as considered to be adenocarcinoma. (b) TP method. A small number of
clusters with irregularly crowded atypical cells are observed in the background, which is clean and devoid of single cells. Since no other such
a cluster was observed in the specimen, this case was diagnosed as AGC (Papanicolaou; original magniﬁcation, x600, resp.).
having been low in this study. However, in early-stage and
the precancerous adenocarcinoma, the cytology is used as
adjuvant method in clinical settings, and it seems that the
cytological diagnosis rate is lower than a real incidence.
Since the numbers limited a thorough statistical analysis
and beneﬁts might not provide a true reﬂection of the
value, they were not presented in this study. Also, while it
would be appropriate to stratify AGC cases according to the
Bethesda Classiﬁcation, however, in our setting diagnosis of
AGC, regardless of the type, would have necessitated further
investigations/followup so that patient would not be placed
at a disservice as Pap smears is generally considered as a
screening modality.
It was thought that the TP method was superior if we
considered equalization of the specimen manufacture and
additive work (e.g., immunostaining/FISH/HPV DNA test).
Therefore, it is important for the screeners to learn the TP
and to get enough experience, when it shifts from the CS to
TP.
5. Conclusion
In summary, this study extends previous work suggesting
that the TP method may become at least as good as CS
in detecting glandular lesions, with enough case experience
and well mastering the criteria. Considering about the
clinical advantages of LBC, it is desirable that TP should be
popularized under the enough experience of this method to
avoid the confusion about the cytological diagnosis. Based
on these results, further larger-scaled studying of this kind
would be encouraged to lead more positive conclusions.
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